Maria Lourdes Garcia Mondragón,Marisol Juana Gomora Pacheco,Patricia Maria Rodriguez Bernal
申请号：
US14648992
公开号：
US20150342921A1
申请日:
2013.11.01
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This invention provides a combination of a hypoglycemic, metformin, and an irreversible intestinal gastric and pancreatic lipase inhibitor, Orlistat, for a better control of obesity than with the monotherapy used with each of them this composition provides “low” doses of both drugs to minimize secondary effects and to make use of the synergic effect of both compounds.
